切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2020, Vol. 10 ›› Issue (03) : 97 -100. doi: 10.3877/cma.j.issn.2095-2015.2020.03.001

所属专题: 文献

述评

加强炎症性肠病的慢病管理体系建设
刘同亭1,()   
  1. 1. 250031 济南,联勤保障部队解放军第九六〇医院
  • 收稿日期:2019-12-04 出版日期:2020-06-01
  • 通信作者: 刘同亭
  • 基金资助:
    联勤保障部队军事理论科研项目(19LBJ10068)

To strengthen the construction of chronic disease management system for inflammatory bowel diseases

Tongting Liu1,()   

  1. 1. The 960th Hospital of the PLA Joint Logistic Support Force, Jinan 250031, China
  • Received:2019-12-04 Published:2020-06-01
  • Corresponding author: Tongting Liu
  • About author:
    Corresponding author: Liu Tongting, Email:
引用本文:

刘同亭. 加强炎症性肠病的慢病管理体系建设[J/OL]. 中华消化病与影像杂志(电子版), 2020, 10(03): 97-100.

Tongting Liu. To strengthen the construction of chronic disease management system for inflammatory bowel diseases[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2020, 10(03): 97-100.

炎症性肠病(IBD)主要包括克罗恩病和溃疡性结肠炎两种类型。我国流行病学资料统计数据显示,IBD患病率、发病率近年均呈上升趋势,且呈现一定的地域性。IBD具有难治愈、易反复、致残率高的特点,已成为我国的常见病及慢性病。建立科学、完备、便捷的IBD慢病管理体系,避免危险因素,对降低IBD复发率具有重要意义。

Inflammatory bowel disease (IBD) mainly includes two major types of Crohn's disease (CD) and ulcerative colitis (UC). The existing epidemiological data in China show that the prevalence and incidence of IBD are on the rise. It shows a certain regional. IBD is easy to relapse, destructive, crippling, and it has become a common and chronic disease in China. Studies have found that effective management and avoidance of risk factors can reduce the recurrence rate of IBD. Therefore, it is of great significance to establish a scientific, complete and convenient chronic diseases management system for IBD.

1
He Y, Mao R, Chen F, et al. Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study [J]. Therap Adv Gastroenterol, 2017, 10(5): 397-406.
2
Leddin D, Tamim H, Levy AR. Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study [J]. BMC Gastroenterol, 2014, 14: 140.
3
Park SH, Kim YJ, Hoon RK, et al. A 30-year trend analysis in the epidemiology of inflammatory bowel disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015 [J]. J Crohns Colitis, 2019, 13(11): 1410-1417.
4
何琼,李建栋. 炎症性肠病流行病学研究进展[J]. 实用医学杂志, 2019, 35(18): 2962-2966.
5
中华医学会消化病学分会炎症性肠病学组. 建立全国通用的炎症性肠病诊治过程的关键性质量控制指标的共识意见[J]. 中华炎性肠病杂志, 2017, 1(1): 12-19.
6
Satsangi J, Jewell DP, Rosenberg WM, et al. Genetics of inflammatory bowel-disease [J]. Gut, 1994, 35(5): 696-700.
7
Ahmad T, Satsangi J, McGovern D, et al. Review article: the genetics of inflammatory bowel disease [J]. Aliment Pharmacol, 2001, 15(6): 731-748.
8
Ellinghaus D, Zhang H, Zeissig S, et al. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies [J]. Gastroenterology, 2013, 145(2): 339-347.
9
Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations [J]. Nat Genet, 2015, 47 (9): 979-986.
10
Zeng Z, Mukherjee A, Zhang H. From genetics to epigenetics, roles of epigenetics in inflammatory bowel disease [J]. Front Genet, 2019, 10(31): 1-17.
11
Helbig KL, Nothnagel M, Hampe J, et al. A case-only study of geneenvironment interaction between genetic susceptibility variants in NOD2 and cigarette smoking in Crohn's disease aetiology [J]. BMC Med Genet, 2012, 10(20): 13-14.
12
Lawrance IC, Murray K, Batman B, et al. Crohn's disease and smoking: Is it ever too late to quit? [J]. J Crohns Colitis, 2013, 7(12): e665-e671.
13
Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific [J]. Gut, 2015, 64(7): 1063-1071.
14
Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study [J]. J Gastroenterol Hepatol, 2013, 28(7): 1148-1153.
15
Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease [J]. Gastroenterology, 1999, 117(1): 73-81.
16
Jung SH, Saxena A, Kaur K, et al. The role of adipose tissue- associated macrophages and T lymphocytes in the pathogenesis of inflammatory bowel disease [J]. Cytokine, 2013, 61(2): 459-468.
17
Bilski J, Mazur-Bialy AI, Brzozowski B, et al. Moderate, exercise training attenuates the severity of experiment alrodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles [J]. Mediators Inflamm, 2015: 605071.
18
管丽芳,胡博文,孙琳, 等. 妊娠期炎症性肠病的治疗策略与动态管理[J]. 世界华人消化杂志, 2016, 24(28): 3978-3984.
19
Azer SA. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development [J]. Eur J Gastroenterol Hepatol, 2013, 25(3): 271-281.
20
尹小五,黄晓宇,鲁斌. 炎症性肠病的肠外表现和并发症[J]. 临床消化病杂志, 2015, 27(2): 126-128.
21
Tran N, Coffman JM, Sumino K, et al. Patient reminder systems and asthma medication adherence: a systematic review [J]. J Asthma, 2014, 51(5): 536-543.
22
Uranga JA, López-Miranda V, Lombó F, et al. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease [J]. Pharmacol Rep, 2016, 68(4): 816-826.
23
Zhan YL, Zhan YA, Dai SX. Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review [J]. Clin Nutr, 2018, 37 (1): 123-129.
24
施曼莉,王晨宇. 12周有氧运动对缓解期溃疡性结肠炎患者氧化应激、炎症因子和运动能力的影响[J]. 中国体育科技, 2014, 50(2): 92-97.
25
Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia [J]. Intest Res, 2016, 14(2): 111-119.
[1] 张庆庆, 曲毅睿, 王淑君, 孙凤, 侯晓敏, 耿丽, 孙天骏. 北京市某三甲医院急诊成人烧烫伤的流行病学特征[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 324-328.
[2] 周冠宇, 谭鲁平, 杨亚晶, 李晓光. 1 916例肠道门诊食源性疾病患者病原学监测和临床特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 200-206.
[3] 王婷, 余江. 1 820例罕见病的临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 68-72.
[4] 曹文钰, 郭鹏, 李锦平. 微创手术及非手术方式治疗慢性硬膜下血肿的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 304-309.
[5] 张薇, 郭姗姗. 轻型创伤性脑损伤远期后遗症流行病学的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 117-121.
[6] 宫继斌, 刘光凤, 刘宝, 闫美辰, 庞明敏, 许玥, 孟婷钰, 许娜娜, 范少华, 王昊. 病毒性肺炎合并侵袭性肺曲霉病的研究进展[J/OL]. 中华重症医学电子杂志, 2023, 09(04): 385-390.
[7] 陈利, 杨长青, 朱风尚. 重视炎症性肠病和代谢相关脂肪性肝病间的串话机制研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 385-389.
[8] 朱风尚, 舍玲, 丁永年, 杨长青. 警惕炎症性肠病与少见肠道疾病的鉴别诊断[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(05): 273-276.
[9] 余佳丽, 江学良. 从炎症性肠病治疗策略转变看生物制剂应用进展[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(03): 129-134.
[10] 葛文松. 炎症性肠病双靶向联合治疗[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(02): 65-67.
[11] 廖想, 李爽, 曾瑶. 2012-2021年粪菌移植研究的趋势及热点分析[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(02): 93-99.
[12] 栗慧慧, 林香春. 早发结直肠癌的临床特征及危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 195-200.
[13] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[14] 张姗姗, 叶金锋, 吴立红, 古春明. 广州市肺炎支原体致儿童呼吸系统感染的流行病学及外周血淋巴细胞亚群水平的初步分析[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(01): 33-38.
[15] 韩珂, 王祥耀, 茹楠, 牛晓彤, 向京元, 王妍, 高飞, 柴宁莉, 令狐恩强. 肥胖成人慢性腹泻患病率的系统评价和Meta分析[J/OL]. 中华胃肠内镜电子杂志, 2023, 10(02): 115-120.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?